Sotac Pharmaceuticals (NSE:SOTAC) EPS (Basic) : ₹4.04 (TTM As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Sotac Pharmaceuticals EPS (Basic)?

Sotac Pharmaceuticals's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was ₹0.41. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹4.04.

Sotac Pharmaceuticals's EPS (Diluted) for the three months ended in Sep. 2024 was ₹0.41. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹4.04.

Sotac Pharmaceuticals's EPS without NRI for the three months ended in Sep. 2024 was ₹0.41. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was 4.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Sotac Pharmaceuticals EPS (Basic) Historical Data

The historical data trend for Sotac Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sotac Pharmaceuticals EPS (Basic) Chart

Sotac Pharmaceuticals Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

EPS (Basic)

0.08

-2.14

2.61

3.90

Sotac Pharmaceuticals Quarterly Data
	Mar20	Mar21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EPS (Basic)	Get a 7-Day Free Trial								0.58	0.82	1.49	1.32	0.41

Sotac Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sotac Pharmaceuticals's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(42.813	-	0)	/	10.976
	=	3.90

Sotac Pharmaceuticals's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(4.592	-	0)	/	11.100
	=	0.41

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4.04

Sotac Pharmaceuticals (NSE:SOTAC) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Sotac Pharmaceuticals EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Sotac Pharmaceuticals's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Sotac Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sotac Pharmaceuticals Ltd (NSE:SOTAC) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

Plot No. PF-21, Near ACME Pharma, Opposite Teva Pharma Sanand GIDC-II, Sanand, Ahmedabad, GJ, IND, 382110

Website

https://www.sotacpharma.com

Sotac Pharmaceuticals Ltd is a pharma manufacturer, specializing in the manufacturing of a wide range of pharmaceutical products such as Non-Beta-Lactam (general) tablets, beta-lactam coated tablets, beta-lactam uncoated tablets, Non-Beta-Lactam (general) capsules, beta-lactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray, and cream.

Sotac Pharmaceuticals Headlines

No Headlines